About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, January 17th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

3DIcon Corp. (TDCP)

Mega Stock Picks, PennyTrader Publisher, OTCReporter, and OTCPicks reported earlier on 3DIcon Corp. (TDCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Tulsa, Oklahoma, 3DIcon Corp. is a developer of volumetric, three-dimensional projection and display technologies. The Company is a developer of innovative 3D projection and display technologies designed to produce full color, high-resolution, 360-degree volumetric images. This is a development many consider the next step in 3D display technology. Incorporated in 1995, 3DIcon's shares trade on the OTC Bulletin Board.

CSpace® creates both dense and translucent images. These are for use in mission critical functions such as healthcare, security and defense. CSpace enables viewing inside organs, cargo containers, and baggage, as well as large-scale terrain such as oceans and mountains.
CSpace is a unique 3D display undergoing design to produce high-resolution full-color, true 3D images. The display does not require special viewing aids or glasses. It does not cause viewer fatigue during prolonged use. CSpace is a pure, static 3D display that does not require mechanical rotational movement.

In addition, 3DIcon offers a software product, Pixel Precision®. This product targets the R&D market for developers using Texas Instruments' DLP® line of products. Pixel Precision® is a companion product for the DMD Discovery™ line from Texas Instruments. With Pixel Precision®, every micro-mirror of the DMD Discovery™ is individually addressable and controllable. Pixel Precision® supports both the Discovery™ 1100 and Discovery™ 3000 devices.

In mid-December, 3DIcon announced that the U.S. Patent and Trademark Office granted another patent for CSpace®. Patent # 8,075,139 for the volumetric, three-dimensional projection and display technology was awarded to the University of Oklahoma under their Sponsored Research Agreement (SRA) with 3DIcon.  3DIcon signed an SRA with the University of Oklahoma in 2006 to develop the technology now known as CSpace. As per the terms of the SRA, the University of Oklahoma owns the patent for CSpace and 3DIcon has the exclusive global marketing rights to technology.

3DIcon is building a substantial intellectual property portfolio in the 3D imaging arena. They have a number of additional patents pending.

3DIcon Corp. (TDCP) closed on Tuesday at $0.01, up 6.72%, on 1,036,571 volume with 23 trades. The average volume for the last 60 days is 2,017,682. The 52-week low/high is $0.006/$0.10.

AbTech Holdings, Inc. (ABHD)

Investor Ideas and Greenbackers reported earlier on AbTech Holdings, Inc. (ABHD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AbTech Holdings Inc., through their subsidiary AbTech Industries, Inc., is a full-service environmental technologies and engineering firm. The Company's dedication is to providing innovative solutions to communities, industry and governments addressing issues of water pollution and contamination. They base their products on polymer technologies capable of removing hydrocarbons, sediment and other foreign elements in storm water runoff (ponds, lakes and marinas), flowing water (curbside drains, pipe outflows, rivers and oceans), and industrial process and wastewater. AbTech Holdings lists on the OTCBB; the Company has their corporate headquarters in Scottsdale, Arizona.

The Company's offerings include the innovative new antimicrobial technology Smart Sponge® Plus. This technology is effective in reducing coliform bacteria found in storm water, industrial wastewater, and municipal wastewater. Smart Sponge® Plus is registered with the Environmental Protection Agency (Registration #86256-1). AbTech's Smart Sponge technology is installed in over 15,000 locations across the United States and in eight countries worldwide. The Company currently holds seventeen patents.

The Environmental Protection Agency lists the Company's Ultra‐Urban® Filter series with Smart Sponge® technology as a Best Management Practice (BMP) under the federal guidelines that local governments must follow. Smart Sponge® contains a unique molecular structure that is chemically selective to hydrocarbons, removing up to three times its own weight. Smart Sponge® remains buoyant when saturated and encapsulates hydrocarbons and oils, without leaching.

The Ultra-Urban® Filter with Smart Sponge® is an innovative low-cost BMP. It helps meet NPDES requirements with effective filtration, efficient application, and low maintenance. A true water filter, it ensures water flowing through the system is properly and completely treated. This solution is used to treat stormwater runoff for new or retrofitted sites by absorbing oil, grease, capturing trash, and sediment.

AbTech also has their Smart Pak®, Smart Sponge® Vault, and Smart Sponge® Custom Vault offerings.  The design of their Smart Pak® is for use in new or existing vaults that experience oil and grease pollution accompanied by sediment, trash/debris, hydrocarbons, and coliform bacteria (when specified with Smart Sponge® Plus). Smart Pak® products are constructed out of AbTech's patented Smart Sponge® media that is a non-hazardous material, and can be specified for a new variety of applications.

AbTech Holdings, Inc. (ABHD) closed on Tuesday at $0.57, up 3.64%, on 68,880 volume with 27 trades. The average volume for the last 60 days is 26,053. The 52-week low/high is $0.25/$1.64.

Debt Resolve, Inc. (DRSV)

Stock Guru and PennyStockTicket.com reported earlier on Debt Resolve, Inc. (DRSV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Debt Resolve, Inc. provides lenders, debt buyers, collection agencies, collection law firms and hospitals with a patent-protected online bidding system for the resolution and settlement of consumer debt. The Company also provides a collection and skip tracing solution that is effective at every stage of collection and recovery. Furthermore, the Company provides web-based payment platforms for the financial and healthcare industries. Debt Resolve has their headquarters in Tarrytown, New York.

The Company offers patented technology to resolve consumer debt quickly, privately and with dignity, online. Debt Resolve is a technology services company and a leader and innovator in the asset receivables management industry. They develop and market their patent-based web collection technology to the banking, non-bank finance, debt buyer, receivables management, utility and healthcare industries.

The Company's flagship product is their DR Settle™ system. This is an online collections tool, delivered in an ASP environment and private-labeled for use across multiple segments of the collections industry. DR Settle™ allows late stage consumer debtors to self-cure online and features the Company's patented online bidding system that maximizes the settlement process. Banks and other credit originators, credit card issuers and third-party collection agencies or law firms, as well as assignees and buyers of charged-off consumer debt use DR Settle™.

Debt Resolve also markets their DR Prevent™ product. This is an early stage collection tool. DR Prevent™ is a consumer friendly way to get consumer accounts current and in good standing again. In addition, the Company has their DR Collect™ product. This is a specialized recovery tool tailored specifically for collection agencies and collection law firms. DR Collect bundles DR Settle and certain elements of DR Prevent along with significant automation to eliminate most of the integration process for the agency or law firm.

Debt Resolve initiated a strategy in late 2010 of establishing partnerships with major collection industry providers to drive rapid adoption of the Company's technology in their client bases. They have executed 14 partnerships so far with large billers, collection software providers, payment processors, and analytics vendors. They expect to announce more progress throughout 2012.

Debt Resolve, Inc. (DRSV) closed on Tuesday at $0.10, up 18.75%, on 65,895 volume with 5 trades. The average volume for the last 60 days is 14,349. The 52-week low/high is $0.02/$0.28.

A.P. Pharma, Inc. (APPA)

Stock Fortune Teller reported earlier on A.P. Pharma, Inc. (APPA), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Redwood City, California, A.P. Pharma, Inc. is a specialty pharmaceutical company developing products using their proprietary Biochronomer™ polymer-based drug delivery technology. The Company's focus is primarily on their lead product, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV). A.P. Pharma received a Complete Response Letter on the APF530 NDA; they are targeting the resubmission of the NDA for the first half of 2012.

The Company has additional clinical and preclinical stage programs in the area of pain management. All of these programs use their bioerodible, injectable and implantable delivery systems. Their APF530 is in development for the prevention of acute-onset and delayed-onset chemotherapy-induced nausea and vomiting (CINV). APF530 contains the 5-HT3 antagonist, granisetron, formulated in A.P. Pharma's proprietary Biochronomer™ drug delivery system, which allows therapeutic drug levels to be maintained for five days with a single subcutaneous injection.

Intravenous and oral formulations containing granisetron have approval for the prevention of acute-onset CINV, but not delayed-onset CINV. Granisetron was selected because it is extensively prescribed by physicians based on a well-established record of safety and efficacy. 

In July 2011, A.P. Pharma enrolled their first patient in a thorough QT study for APF530. The study is examining the effect of APF530 on the QT interval in healthy volunteers. In order to start the thorough QT study promptly, the Company decided to separate this study from a planned metabolism study. They expect to report the results of both studies in this first quarter (Q1) of 2012.

The Company's core Biochronomer technology, on which APF530 and their other products have their basis, consists of bioerodible polymers designed to release drugs over a defined period. The Company has completed more than 100 in vivo and in vitro studies demonstrating that their Biochronomer technology is potentially applicable to a range of therapeutic areas. This includes prevention of nausea and vomiting, pain management, control of inflammation and treatment of ophthalmic diseases. A.P. Pharma has a pipeline of other product candidates that use the Biochronomer technology.

A.P. Pharma, Inc. (APPA) closed on Tuesday at $0.25, down 3.85%, on 37,162 volume with 12 trades. The average volume for the last 60 days is 13,859. The 52-week low/high is $0.10/$0.58.

BAZI International, Inc. (BAZI)

OTCPicks and FeedBlitz reported earlier on BAZI International, Inc. (BAZI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Denver, Colorado, BAZI International, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. The Company's main product is BAZI®, a healthy, concentrated, two ounce energy shot. BAZI® contains eight super fruits, including jujube, acai, mangosteen, goji, pomegranate, blueberry, raspberry and seabuckthorn, plus an assortment of phytonutrients, antioxidants, vitamins, and trace minerals.

BAZI® has 6 grams per serving of sugars and naturally energizes (no artificial chemical overload, i.e. less caffeine; less sugar). It is all-natural, with no preservatives, and is sweetened with organic cane. It has premier ORAC value. ORAC value is the Oxygen Radical Absorbance Capacity of food. In providing fuel for the body, there is no crash and burn, and the product is non-addictive. It features an easy open bottle and it is low calorie, at 40 calories per shot.

BAZI International announced in October 2011 that BAZI would sell in Sports Authority stores across the United States.  Sports Authority operates more than 450 stores in 45 states. Earlier BAZI distribution announcements include SportTech, Rite Aid, Atlas Oil, 7-Eleven, Circle-K, Regional Exxon Mobile Distribution and Shell-branded convenience stores, among others.

Debbie Wildrick is Chief Executive Officer of BAZI International. She has 30 years of beverage experience. She held former leadership roles at Fortune 500 companies including 7-Eleven, Inc. and Tropicana North America (Pepsico). Her leadership roles include a strong background in building start-up brands including FRS Healthy Energy and Sundance Juice Sparklers (now known as IZZE), a brand which she helped grow to 100 million dollars in the early 1990's.

BAZI International is currently distributing BAZI® through select retail channels, online, and via their existing database of customers. The Company historically has also sold certain products directly to professional and Olympic athletes and professional sports teams. Their goal is to continue with an endorser program using professional and Olympic athletes to build brand awareness for BAZI® and promote the Company's products.

IBC Advanced Alloys Corp. (BAZI) closed on Tuesday at $0.04, up 33.78%, on 92,500 volume with 5 trades. The average volume for the last 60 days is 25,516. The 52-week low/high is $0.01/$0.39.

Canyon Copper Corp. (CNYC)

Stock Guru reported previously on Canyon Copper Corp. (CNYC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Canyon Copper Corp. is a resource company with two advanced mineral resource properties in the Western United States. The Company formerly went by the name Aberdene Mines Ltd. They changed their name to Canyon Copper Corp. in August of 2006. The Company's shares list on the OTC Bulletin Board and on the TSX Venture Exchange (CNC.V). Canyon Copper has their corporate headquarters in Vancouver, British Columbia.

The Company's New York Canyon property is 30 miles (48 km) east of Hawthorne, Nevada. This property consists of 24 patented claims covering 420 acres (170 hectares) of which 18 are leased; and 1,293 unpatented mining claims covering approximately 25,860 acres (10,781 hectares). Therefore, this is for a total area of approximately 42 sq. miles.

For the Longshot Ridge target, Canyon Copper has obtained an indicated mineral resource estimate, at a cut-off grade of 0.2 percent copper, of 16,250,000 tons at an average grade of 0.43 percent Cu, and an inferred mineral resource estimate, at cut-off grade of 0.2 percent copper, of 2,900,000 tons at an average grade of 0.31 percent Cu.

The Company's objectives include an aggressive drill program to expand the current NI 43-101 Oxide Copper resource. They are also working to develop a database for an economic scoping study. Furthermore, they are establishing a project pipeline of other significant Copper deposits.

In December 2011, Canyon Copper advised that the new assay results for the 33 drill hole program carried out on Longshot Ridge in 2006 have been received and will be applied in a recalculation of the 2010 resource estimate, which mineralization was modeled using only those holes drilled in the years previous to the 2006 program. The assays are from drill holes that were mainly outlining the Longshot Ridge copper oxide deposit or infilling gaps in the original drill pattern. They will be included in a revised resource estimate when they have been audited by an independent consultant for quality assurance (QA) and quality control (QC) and incorporated in the data base.

Canyon Copper made a recent entry into an assignment agreement to acquire the Moonlight copper oxide deposit. This is subject to the approval of the TSX Venture Exchange.

Canyon Copper Corp. (CNYC) closed on Tuesday at $0.14, even with yesterday’s close, on 14,286 volume with 3 trades. The average volume for the last 60 days is 23,440. The 52-week low/high is $0.08/$0.45.

Prophecy Coal Corp. (PCY.TO)

Today we are highlighting Prophecy Coal Corp. (PCY.TO), here at the QualityStocks Daily Newsletter.

Trading on the Toronto Stock Exchange, Prophecy Coal Corp. engages in developing energy projects in Mongolia. The Company has surface minable thermal coal resources on two coal properties in Mongolia. Mongolia has extensive reserves of high-quality coal, suitable for domestic use and export to neighboring China and other high-demand Asian markets. Prophecy Coal is the controlling shareholder of Prophecy Platinum Corp. (NKL.V). The Company has their headquarters in Vancouver, British Columbia. They also have an office in UlaanBataar, Mongolia.

Prophecy Coal controls more than 1.4 billion tonnes of open-pittable thermal coal in Mongolia (839 Mt measured, 579 Mt indicated) between two distinct deposits. In November 2011, the Mongolian government issued Prophecy an official permit to construct a 600MW power plant at the site of their Chandgana deposit. Prophecy's second project at Ulaan Ovoo was commissioned for production in November 2010. Ulaan Ovoo contains 209 million tonnes of measured and indicated coal and Chandgana contains 1,211 million tonnes of measured and indicated coal.

Prophecy Coal's Ulaan Ovoo coalmine is in production and their Chandgana Mine-Mouth Power Plant has undergone permitting. Prophecy Coal also holds the Okeover Property (copper-molybdenum) and the Titan Vanadium-Titanium-Iron projects in Canada.

Today, Prophecy Coal announced that they received a positive feasibility study for their 600 MW Chandgana Mine-Mouth Power Project in Central Mongolia. The Report underwent preparation independently by Ralf Thomsen, Project Manager at Steag (a German firm specializing in the planning, financing, construction and operation of highly efficient, thermal power plants for fossil fuels).

The scope of the feasibility study covers technical specification, deployment, and financial analysis of a 4 x 150 MW thermal power plant to undergo construction adjacent to Prophecy's Chandgana Tal coal deposit. The Power Plant and the coal deposit have respectively already received a construction license and a mining license in 2011. Engineering, Procurement & Construction Management (EPCM) selection and Project Financing Discussion are underway. The expectation is that they will conclude this year.

Prophecy Coal Corp. (PCY.TO) closed on Tuesday at $0.46, up 8.33%, on 3,168,990 volume. The 52-week low/high is $0.39/$1.14.

E-Waste Systems, Inc. (EWSI)

FeedBlitz reported earlier on E-Waste Systems, Inc. (EWSI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

E-Waste Systems, Inc.'s goal is to be a leading provider of waste electric and electronic equipment processing services in key jurisdictions globally. The Company was formerly known as Dragon Beverage, Inc. They changed their name to E-Waste Systems, Inc. in May 2011. E-Waste Systems lists on the OTC Bulletin Board. The Company has their corporate headquarters in London, England. They also have an office in Los Altos, California.

E-Waste Systems will focus mainly on e-waste recycling, repair/refurbishment, and electronic asset recovery. The Company will also focus on opportunistic efforts in service, parts distribution, and precious metals recycling.

For Repair/Refurbishing, the Company can handle a broad array of products and materials. They will initially target circuit boardbased electronics. Concerning Asset Recovery, E-Waste Systems will sell reclaimed parts and components to product support and repair companies for reuse in electronics products. For E-Waste Recycling, they will sell segregated raw materials (plastics, steel, aluminum, glass, and precious metals) to downstream processors for resale and reprocessing into raw materials for use in manufacturing. They will market services and collect fees, either directly or indirectly from governmental initiatives, and from the providers of electronic asset materials.

In November 2011, E-Waste Systems announced that they entered into a business agreement with Fine Resources, Inc., dba Resource Recycling, a commodity and electronic waste trading firm based in Daphne, Alabama. Through this partnership, E-Waste Systems will expand upon their capability to source large volumes of end-of life electronics.

E-Waste Systems earlier closed their first U.S. acquisition in Ohio. They have announced plans to make further acquisitions in the U.S. to create a unified platform of businesses offering high-quality solutions to the management of Waste Electrical and Electronic Equipment (WEEE). E-Waste Systems is actively building relationships with businesses and other organizations facing regulatory and/or other mandates for the handling of their e-waste.

E-Waste Systems, Inc. (EWSI) closed on Tuesday at $.125, up 19.05%, on 110,800 volume with 26 trades. The average volume for the last 60 days is 253. The 52-week low/high is $0.01/$1.05.
graphic

The QualityStocks
Company Corner

graphic
graphic

Strategic American Oil Corp. (SGCA)

The QualityStocks Daily Newsletter would like to spotlight Strategic American Oil Corp. (SGCA). Today, Strategic American Oil Corp. closed trading at $0.08, up 6.67%, on 31,500 volume with 6 trades. The stock's average daily volume over the past 60 days is 204,648 with a 52-week low/high of $0.055/$0.20.

Strategic American Oil Corp. (SGCA) is an oil and natural gas exploration and production company with operations in Texas, Louisiana, and Illinois. Through the recent acquisition of Galveston Bay Energy, the company has significantly increased its existing increased oil and gas production as well as cash flow. In addition to advancing its current projects, Strategic American Oil continues to seek accretive acquisitions of production, reserves or other companies with promising prospects.

To date, Strategic American Oil has established a land portfolio with an aggregate gross 5,236 developed and undeveloped acres in Texas and Illinois alone. With this acreage, the company has identified new exploration targets and is applying advanced technology to maximize production. The company has also leased land positions hosting previously producing wells with the goal of enhancing or reestablishing production.

In September 2011, the company acquired SPE Navigation I, LLC, which included over $4 million in liquid assets and a $10 million working capital bank line, in exchange for 95 million restricted shares of common stock. The previous owners, who founded and developed Hyperdynamics Corp. (NYSE: HDY), now own an even greater stake in Strategic American Oil. To date, these owners have provided more than 70% of the company's capital for acquisitions and are committed to long term shareholder value.

Strategic American Oil is aggressively leasing, drilling, and acquiring projects at various stages of development to become a mid-tier U.S. oil and gas developer. The company is currently producing oil and gas, and making significant progress on its keystone projects in Texas and Illinois. Leveraging its technical expertise, promising portfolio and strong financial condition, the company is in an advantageous position to experience remarkable growth in the near term future. Disclaimer

Strategic American Oil Corp. Blog

Strategic American Oil Corp. News:

Strategic American Oil Corporation Increases Proved Reserves

Strategic American Oil Corporation Completes New Zone in Welder Ranch Well

Strategic American Oil Announces Removal of Auditors' "Going Concern" Opinion

FluoroPharma Medical, Inc. (FPMI)

The QualityStocks Daily Newsletter would like to spotlight FluoroPharma Medical, Inc. (FPMI). Today, FluoroPharma Medical, Inc. closed trading at $0.8250 Down off by 2.94% on 87,700 volume with 26 trades. The stock’s average daily volume over the past 60-day daily average volume is 15,451 with a 52-week low/high of $0.56/$2.15.

Today, FluoroPharma Medical, Inc. announced that President & CEO, Thijs Spoor, will present at Noble Financial Capital Markets' Eight Annual Equity Conference before prospective corporate partners and investors on Tuesday, January 17th at 11:30 AM ET. The Company's presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida and will be webcast with live audio and high-definition video of the presentation. A copy of the presentation materials will also be available on the Company's website www.fluoropharma.com on the Events page.

FluoroPharma Medical, Inc. (FPMI) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

FluoroPharma Medical, Inc. Company Blog

FluoroPharma Medical, Inc. News:

FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference

FluoroPharma Announces Addition to the Board of Directors Reflecting Strong Focus on the Future

FluoroPharma Announces Aggregate of $7M Capital Raise in 2011

Beacon Enterprise Solutions Group, Inc. (BEAC)

The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.30, even with yesterday's close, on 44,100 volume with 9 trades. The stock’s average daily volume over the past 60-days is 37,686 with a 52-week low/high of $0.14/$0.70.

Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.

Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.

Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.

Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer

Beacon Enterprise Solutions Group, Inc. Blog

Beacon Enterprise Solutions Group, Inc. News:

Beacon Enterprise Solutions Provides Earnings Call Webcast for Fiscal 2011 Financial Results

Beacon Enterprise Solutions Reports Fiscal 2011 Financial Results

Beacon Reports Significant Increases in Service Ticket Volume and Locations Served

TiVUS, Inc. (TIVU)

The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0003, even with yesterday's close, on 8,986,833 volume with 7 trades. The stock’s average daily volume over the past 60-day daily average volume is 18,443,258 with a 52-week low/high of $0.0001/$0.06.

TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

TiVUS, Inc. Company Blog

TiVUS, Inc. News:

TiVUS Commences Live Hotel TV Ad-Insertions

TiVUS Successfully Completes Two-Year Audit

TiVUS Commences East Coast Advertising Sales

Antares Pharma, Inc. (AIS) Licenses Rights to Oxybutynin Gel to Daewoong Pharmaceuticals

Today, Antares Pharma, Inc. announced that it has licensed its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd., exclusively, for marketing in South Korea. Antares will receive upfront payments and regulatory and sales based milestones, in addition to royalties on net sales for the product.

The FDA-approved Oxybutynin Gel has demonstrated to be an effective and safe treatment for overactive bladder (OAB). The product’s active ingredient is delivered transdermally; as such, the liver metabolizes the product differently than orally administered oxybutynin, resulting in a low level of side effects, such as dry mouth and constipation. Clear and odorless, the product is dispensed in a metered-dose pump.

“We are very pleased to enter this collaboration with Daewoong, a leading pharmaceutical company in South Korea with over 700 sales representatives targeting urologists, general practitioners and hospitals for our oxybutynin gel product,” said Paul K. Wotton, Ph.D., Antares’ President and CEO. “This is the third partnering agreement we have signed within the past six months as we continue to execute our strategic plan with premier partners and expand the business base of Antares. It also provides a potential near term revenue generating opportunity from product sales.”

Dr. Jong Wook Lee, President and CEO of Daewoong Pharmaceuticals Co. Ltd. added, “We are very delighted to announce this collaboration with Antares and are ready to strengthen and expand our urology portfolio in Korea. There is a significant unmet medical need for OAB therapeutics in Korea. Antares’ oxybutynin gel product will provide a safe and effective therapy for OAB patients. We are dedicated to its successful development in Korea as the therapy reflects Daewoong’s long-term commitment to provide safer, more effective treatment options for OAB patients.”

UFood Restaurant Group (UFFC) Grants Franchise Agreement for 10 UFood Grill Units in British Columbia

UFood Restaurant Group, Inc., a franchisor and operator of fast-casual food service restaurants, today announced it has granted a territorial franchise agreement to ASA Capital Alliance for the development of 10 UFood Grill units in British Columbia. The first unit is slated to open in Vancouver by April 2012.

ASA is an organization focusing on operating high-quality food establishments in the Vancouver metro market. ASA currently operate two Persian cuisine Cazba Restaurants in North Vancouver. The organization’s focus is complementary to UFood’s UFood Grill, which offers on healthier food choices, serving low calorie and low fat food, and when possible, serves meals that are antibiotic and hormone-free, gluten-free as well as natural, grass-fed beef and cage-free eggs.

“I am proud to bring UFood’s better-for-you quick-service model to Canada,” ASA CEO Zaid Al Chalabi stated in the press release. “Like Americans, Canadians are also focused on nutrition and health. UFood is a perfect solution for those with busy lifestyles who care about eating well.”

UFood has plans to expand into the military channel and will open three units at Aberdeen Proving Ground in Maryland, the first of which is under construction and the second is planned for construction start in eight weeks. UFood has airport locations in Boston, Cleveland and Dallas, and is approved for two more locations in the Salt Lake City airport, which will open in April of this year.

“The executives of ASA embrace a long family history of restaurant experience, real estate selection expertise, financial capability, local immersion and commitment to serving their customers the highest quality food,” said UFood CEO George Naddaff. “Mr. Chalabi’s proven success with the Cazba Restaurants and his drive to introduce healthy affordable food alternatives to consumers make him and his organization the ideal partner for UFood to expand into British Columbia. We look forward to working toward our first opening this spring.”

For more information visit www.ufoodgrill.com

InVivo Therapeutics (NVIV), Geisinger Health System to Conduct Clinical Studies for Treatment of Chronic Pain Associated with Peripheral Nerve Injury

InVivo Therapeutics Holdings Corp., developer of technologies to treat spinal cord injuries (SCI), and integrated health services organization Geisinger Health System today announced their collaborative research to conduct a preclinical study using InVivo’s injectable biocompatible hydrogel to treat chronic pain caused by peripheral nerve compression.

InVivo said it plans to submit data from the study to the U.S. Food and Drug Administration (FDA) in 2012, marking the company’s first technology to treat degenerative neurologic conditions outside of the spinal cord.

The company noted that approximately 3.2 million chronic pain injections are performed in the U.S. each year to treat patients with back, leg, neck and arm pain. This statistic reflects an estimated $15 billion annual market for time-released anti-inflammatory therapies.

“Chronic peripheral nerve compression can have a devastating impact on an individual’s quality of life and even impair one’s ability to function on a day-to-day basis,” Dr. Jonathan Slotkin, a renowned expert in spinal cord injury treatment and director of spinal surgery and spinal cord injury research at Geisinger Health System’s Neurosciences Institute, stated in the press release. “InVivo’s innovative technology platform has already demonstrated success in the treatment of traumatic spinal cord injury in several study models, and we look forward to examining how this latest technology performs in this new application.”

Geisinger and InVivo will conduct their research in the Tapinos Lab of Molecular Neuroscience at the Weis Center for Research and the Slotkin Lab of Spinal Cord Injury Research at the Geisinger Clinic’s Neurosciences Institute. The endpoint of the study will be to determine the efficacy of injectable hydrogels for the controlled release of drugs to alleviate chronic pain resulting from compression-induced peripheral nerve damage.

Dr. Ed Wirth, InVivo’s chief science officer and one of the world’s foremost experts in spinal cord injury treatment and regenerative medicine, noted the prestige of the Geisinger research facility and the anticipated outcome of the upcoming research.

“The Geisinger Neurosciences Institute is one of the premiere facilities in the country for the study of innovative diagnostic and treatment approaches to neurologic disorders,” Dr. Wirth stated. “We believe there is tremendous potential for our technology to treat other neurological conditions beyond spinal cord injury, and we are eager to move forward in bringing these therapies one step closer to broad market availability.”

For more information visit www.invivotherapeutics.com or www.geisinger.org

Applied DNA Sciences, Inc. (APDN) Patented DNA Security Solutions Used to Obtain Convictions of Major Crimes in Europe and US

Applied DNA Sciences, Inc., a provider of DNA-based security, anti-counterfeiting technology, law-enforcement and product-authentication solutions, announced that its patented technology played a major role in the conviction of eleven drug cartel members in the United Kingdom. APDN has been working with the United Kingdom law enforcement for years to reduce the number of cash-in-transit attacks and this is a progression in the utilization of their DNA technology to positively identify evidence, cash or merchandise. The ADN product used was the SigNature DNA which uses the DNA from plants to mark and authenticate products in a unique manner that cannot be copied, serving as definitive, forensic proof of authentication for court purposes.

The company’s announcement stems from a difficult drug case where sophisticated, devious and experienced professional criminals who were running a major drug distribution network were able to avoid detection and conceal activities. The key to the case was irrefutable evidence derived from the $15,000 in cash that carried APDN’s SigNature DNA, which was seized during a police raid. The cash tied him to an earlier robbery and demonstrated his role as the stolen money launderer. After conviction of the leader, most of the other ten cartel members pleaded guilty.

“Our technologies are being used to obtain convictions in major crimes throughout Europe and now the US. In cases like this, where sophisticated criminals can be difficult to find and convict, our SigNature DNA makes a watertight case. It proves legally and without doubt that the criminal is linked to a specific crime. We are proud to help bring security and safety to citizens wherever our products are used, whether protecting cash, ATM machines, banks, jewelers or pharmacies,” said Dr. James Hayward, CEO, APDN in a press release.

APDN also has SmartDNA (TM) which covers criminals in a dye as they leave the scene of a crime. It demonstrated success in six cases in Sweden last year, including robberies of Swedish jewelers and drug arrests. Drug enforcement officers with the Illinois State Police are testing SmartDNA for both convicting and deterring criminals. It is also being used by US banks.

“We are completely convinced by the deterrent capacity of SmartDNA and have installed it in all our branches to protect tellers, customers and ATMs. Based on our experience with this technology, we are confident that DNA solutions could help tighten the security of pharmacies throughout the United States,” said Joseph Perri, CEO, Gold Coast Bank in the press release.

For more information, please visit www.adnas.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

SmallCap Fortunes
(ESLRQ)

2.

PennyOmega
(KUTV)

3.

Breaking Stock Reports
(FNSCQ)

graphic
By The Numbers Charts
QualitystockTwits

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251